2019

1. Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

   Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 55-64